62973-3
ClinicalPhenX - gastroesophageal reflux disease (GERD) symptoms protocol 191101
Definition
The Gastroesophageal Reflux Disease Questionnaire (GerdQ) is a 6-item questionnaire that helps identify patients with gastroesophageal reflux disease (GERD). Patients are asked to report frequency of symptoms over the past 7 days. If the administration of the GerdQ produces a positive score for GERD, the Gastrointestinal Working Group (WG) recommends performing a pH impedence test to confirm the results and determine disease severity. Please see the Gastrointestinal WG Supplemental Information for a pH impedence test protocol. The Gastroesophageal Reflux Disease Questionnaire (GerdQ) is a proprietary instrument that is available for use with permission from AstraZeneca. To obtain permission, contact AstraZeneca at PROinformation@astrazeneca.com and complete a License Agreement.
LOINC 6-Axis Classification
Component
PhenX - gastroesophageal reflux disease (GERD) symptoms protocol 191101
Property
-
Time Aspect
Pt
System
^Patient
Scale Type
-
Method Type
PhenX
Details
Class
PANEL.PHENX
Order/Observation
N/A
Short Name
GERD symptoms proto
Related Names
Frequently Asked Questions
What is LOINC code 62973-3?
LOINC code 62973-3 identifies "PhenX - gastroesophageal reflux disease (GERD) symptoms protocol 191101". The Gastroesophageal Reflux Disease Questionnaire (GerdQ) is a 6-item questionnaire that helps identify patients with gastroesophageal reflux disease (GERD). Patients are asked to report frequency of symptoms over the past 7 days. If the administration of the GerdQ produces a positive score for GERD, the Gastrointestinal Working Group (WG) recommends performing a pH impedence test to confirm the results and determine disease severity. Please see the Gastrointestinal WG Supplemental Information for a pH impedence test protocol. The Gastroesophageal Reflux Disease Questionnaire (GerdQ) is a proprietary instrument that is available for use with permission from AstraZeneca. To obtain permission, contact AstraZeneca at PROinformation@astrazeneca.com and complete a License Agreement.
What does 62973-3 measure?
This code measures PhenX - gastroesophageal reflux disease (GERD) symptoms protocol 191101 in ^Patient. It belongs to the PANEL.PHENX class in the LOINC classification.
What is LOINC?
LOINC (Logical Observation Identifiers Names and Codes) is a universal standard for identifying laboratory and clinical observations. It is maintained by the Regenstrief Institute and used worldwide for health data exchange.